Figures & data
Figure 1. (a) The synthesis procedure of CLO-BSA; (b) Identification of CLO-BSA by SDS-PAGE; (c) The titer curve of the four mice pAb; (d) Sensitivity identification of the No.2 mouse pAb.
![Figure 1. (a) The synthesis procedure of CLO-BSA; (b) Identification of CLO-BSA by SDS-PAGE; (c) The titer curve of the four mice pAb; (d) Sensitivity identification of the No.2 mouse pAb.](/cms/asset/c34361ae-95e2-4b28-b363-5b244b8a85d1/cfai_a_2001439_f0001_oc.jpg)
Figure 2. (a) The identification of the mAb (34F10) subclass; (b) The sensitivity of 34F10 identified by ic-ELISA.
![Figure 2. (a) The identification of the mAb (34F10) subclass; (b) The sensitivity of 34F10 identified by ic-ELISA.](/cms/asset/9d2e0c9e-a541-4a35-a72d-9e4eaee56843/cfai_a_2001439_f0002_ob.jpg)
Table 1. The cross-reaction of mAb with other agonist drugs.
Figure 4. Elimination of matrix effects in (a) pig urine sample and (b) pork sample; (c) IC50values for pig urine sample and pork sample following different dilutions with PBS; ND: not detected.
![Figure 4. Elimination of matrix effects in (a) pig urine sample and (b) pork sample; (c) IC50values for pig urine sample and pork sample following different dilutions with PBS; ND: not detected.](/cms/asset/b29ac035-ab53-4cae-a55c-c7d05d49fdb6/cfai_a_2001439_f0004_oc.jpg)
Table 2. The recovery experiment of the ic-ELISA for CLO in pig urine and pork samples.